NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].
Show details| DRUG | CAS REGISTRY NUMBER | MOLECULAR FORMULA | STRUCTURE |
|---|---|---|---|
| Oliceridine | 1401028-24-7 | C22-H30-N2-O2-S |
|
- PubChem SubstanceRelated PubChem Substances
- Review Opioids, Opioid Antagonists.[LiverTox: Clinical and Researc...]Review Opioids, Opioid Antagonists.. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012
- ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy.[J Pain Res. 2019]ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy.Bergese SD, Brzezinski M, Hammer GB, Beard TL, Pan PH, Mace SE, Berkowitz RD, Cochrane K, Wase L, Minkowitz HS, et al. J Pain Res. 2019; 12:3113-3126. Epub 2019 Nov 14.
- APOLLO-2: A Randomized, Placebo and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-Biased Ligand at the μ-Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty.[Pain Pract. 2019]APOLLO-2: A Randomized, Placebo and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-Biased Ligand at the μ-Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty.Singla NK, Skobieranda F, Soergel DG, Salamea M, Burt DA, Demitrack MA, Viscusi ER. Pain Pract. 2019 Sep; 19(7):715-731. Epub 2019 Jun 24.
- Review Oliceridine: A Novel Drug for the Management of Moderate to Severe Acute Pain - A Review of Current Evidence.[J Pain Res. 2021]Review Oliceridine: A Novel Drug for the Management of Moderate to Severe Acute Pain - A Review of Current Evidence.Tan HS, Habib AS. J Pain Res. 2021; 14:969-979. Epub 2021 Apr 14.
- Oliceridine for the Management of Acute Postoperative Pain.[Ann Pharmacother. 2021]Oliceridine for the Management of Acute Postoperative Pain.Liu Y, Hu Q, Yang J. Ann Pharmacother. 2021 Oct; 55(10):1283-1289. Epub 2021 Jan 11.
- [Table, CHEMICAL FORMULA AND STRUCTURE]. - LiverTox[Table, CHEMICAL FORMULA AND STRUCTURE]. - LiverTox
- Quizartinib - LiverToxQuizartinib - LiverTox
- Amisulpride - LiverToxAmisulpride - LiverTox
- Pirtobrutinib - LiverToxPirtobrutinib - LiverTox
- Naxitamab - LiverToxNaxitamab - LiverTox
Your browsing activity is empty.
Activity recording is turned off.
See more...